1. CMV, BKV, HHV-6B, AdV, and EBV Kinetics after Allogeneic Hematopoietic Cell Transplantation 
Joshua A. Hill, MD, Bryan Mayer, PhD, Hu Xie, MS, Wendy M. Leisenring, Meei-Li Huang, Terry L. Stevens-Ayers, Filippo Milano, MD, PhD, Colleen Delaney, MD, MSc, Keith R. Jerome, MD, PhD, Danielle Zerr, MD, MPH, Garrett Nichols, MD, MS, Michael J. Boeckh, MD, Joshua T. Schiffer, MD, MS 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S165-S166 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Proportion of patients with any s pecific virus detected at any time through day 100, subdivided by most frequent occurrences of s ingle or concurrent viral detection
Biology of Blood and Marrow Transplantation  , S165-S166DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Linear regression models for mean population viral load stratified by A) acute GVHD grade ≥3 and B) HCT type. Adjusted for sex, race, age, disease risk; Conditioning, and concurrent detection of other viruses. * = p < 0.05, ** = p<0.001
Biology of Blood and Marrow Transplantation  , S165-S166DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 3
Proportion of patients with detection of each virus by week after HCT
Biology of Blood and Marrow Transplantation  , S165-S166DOI: ( /j.bbmt )
Copyright © Terms and Conditions